In model organisms like *Saccharomyces cerevisiae* or *Caenorhabditis elegans*, genetic manipulation of enzymes involved in glutathione synthesis or regeneration is employed to investigate the impact of cellular redox state on lifespan and healthspan
This GLP-1 release stimulates the brain to suppress appetite, enhances glucose disposal, and improves insulin sensitivity, contributing to metabolic benefits like reduced food intake, obesity, and better glucose tolerance
Studies show that dual therapy can enhance metabolic improvements compared to either medication alone
I don't have a specific proposal
and nearly 95% reverted from prediabetes to normoglycemia
"Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes" in The New England Journal of Medicine, vol